C07J 41/0044
With an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where
Official title: {with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group}
C07J41/0044 (With an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where) appears on 46 US grants and 51 published applications in this corpus.
Search patents in C07J- Granted patents
- 46
- Published applications
- 51
- Assignees
- 36
- Inventors
- 150
- Latest grant
- 9 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 3 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 4 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 1 | 3 |
| 2013 | 0 | 0 |
| 2014 | 0 | 2 |
| 2015 | 2 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 1 |
| 2019 | 2 | 3 |
| 2020 | 5 | 4 |
| 2021 | 2 | 1 |
| 2022 | 2 | 3 |
| 2023 | 2 | 9 |
| 2024 | 3 | 6 |
| 2025 | 4 | 3 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Neuroactive steroids and their methods of use9 Sep 2025US 12,410,210 B2Sage Therapeutics, Inc.
- Tripartite androgen receptor eliminators, methods and uses thereof3 Jun 2025US 12,319,681 B2SPG Therapeutics, Inc.
- Neuroactive steroids and their methods of use1 Apr 2025US 12,264,177 B2Sage Therapeutics, Inc.
- Neuroactive steroids and their methods of use18 Mar 2025US 12,252,509 B2Sage Therapeutics, Inc.
- Neuroactive steroids and their methods of use4 Jun 2024US 11,999,765 B2Sage Therapeutics, Inc.
- Compositions and methods for treating cns disorders9 Apr 2026US 2026/0098053 A1Sage Therapeutics, Inc.
- Compounds for the treatment of cancer28 Aug 2025US 2025/0268919 A1Amneal Pharmaceuticals, LLC
- Therapeutically active steroidal derivatives21 Aug 2025US 2025/0263431 A1Organon R&D Finland Ltd.
- Neuroactive steroids and their methods of use15 May 2025US 2025/0154194 A1Sage Therapeutics, Inc.
- Neuroactive steroids and their methods of use17 Oct 2024US 2024/0343756 A1Sage Therapeutics, Inc.
Most cited
By later US patents
- Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents40US 5,464,871 AOctamer, Inc. · 1995
- Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents29US 5,670,518 A1997
- Halo-nitro-isoquinolinone compounds and pharmaceutical compositions thereof25US 5,652,367 A1997
- Novel 19-nor-steroids21US 4,874,754 ARoussel Uclaf · 1989
- Synergistic compositions useful as anti-tumor agents15US 5,877,185 AOctamer, Inc. · 1999